Biotech entity
pharma is the sole category represented across all 1 tracked stories. Kansas Senate is most often covered alongside CVS Caremark, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 2.5 across the same-window beat baseline.
Last mentioned: Mar 24, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Kansas Senate is most often covered alongside CVS Caremark, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 2.5 across the same-window beat baseline. The 6 average consequence score is above the beat benchmark of 5.9 in the same window. Kansas Senate appears in 1 tracked Biotech story from March 24, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 20 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Kansas Senate. Shared-story counts are live from our verified record — not editorial picks.
The Kansas Legislature has passed a significant bill aimed at increasing oversight of Pharmacy Benefit Managers (PBMs), the intermediaries between insurers and drug manufacturers. The legislation seeks to address rising drug costs and ensure greater transparency in how these middlemen operate within the state's healthcare ecosystem.
Kansas Senate is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
